Recurrent infectious diseases in human CD53 deficiency

Clinical and Diagnostic Laboratory Immunology

Volumn 4, Issue 2, 1997, Pages 229-231

  Mollinedo, Faustino ^a   Fontan, Gumersindo ^b   Barasoain, Isabel ^c   Lazo, Pedro A ^d  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD53 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; INFECTION; MALE; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030890320     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.4.2.229-231.1997     Document Type: Short Survey

References (23)

1. Adachi, M., T. Taki, Y. Ieki, C.-L. Huang, M. Higashijama, and M. Miyake. 1996. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res. 56:1751-1755.
2. Anderson, D. C., T. K. Kishimoto, and C. W. Smith. 1995. Leukocyte adhesion deficiency and other disorders of leukocyte adherence and motility, p. 3955-3994. In C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle (ed.), The metabolic and molecular bases of inherited disease, 7th ed. McGraw-Hill, New York, N. Y.
3. Angelisova, P., C. Vleek, I. Stefanova, M. Lipoldova, and V. Horejsi. 1990. The human leucocyte surface antigen CD53 is a protein structurally similar to CD37 and MRC OX-44 antigens. Immunogenetics 32:281-285.
4. Barcia, R., S. Garcia-Vargas, L. Boscá, and P. A. Lazo. 1996. CD53 antigen F and epidermal growth factor induce similar changes in the pattern of phorbol ester binding in a B cell lymphoma. Cell. Immunol. 169:107-112.
5. Bell, G. M., J. B. Bolen, and J. B. Imboden. 1992. Association of src-like protein tyrosine kinases with the CD2 cell surface molecule in rat T lymphocytes and natural killer cells. Mol. Cell. Biol. 12:5548-5554.
6. Boscá, L., and P. A. Lazo. 1994. Induction of nitric oxide release by MRC OX-44 (anti CD53) through a protein kinase C dependent pathway in rat macrophages. J. Exp. Med. 179:1119-1126.
7. Campanero, M. R., R. I'ulido, J. L. Alonso, J. P. Pivel, F. X. Pimentel-Muinos, M. Fresno, and F. Sanchez-Madrid. 1991. Down-regulation by tumor necrosis factor-α of neutrophil cell surface expression of the sialo-phorin CD43 and the hyaluronate receptor CD44 through a proteolytic mechanism. Eur. J. Immunol. 21:3045-3048.
8. Dong, J.-T., P. W. Lamb, C. W. Rinker-Schaefer, J. Vukanovic, T. Ichikawa, J. T. Isaacs, and J. C. Barret. 1995. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268:884-886.
9. Forehand, J. R., W. M. Nauseef, J. T. Cunutte, and R. B. Jhonston. 1995. Inherited disorders of phagocyte killing, p. 3995-4026. In C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle (ed.), The metabolic and molecular bases of inherited disease, 7th ed. McGraw-Hill, New York, N.Y.
10. Gonzalez, M. E., F. Pardo-Manuel de Villena, E. Fernandez-Ruiz, S. Rodriguez de Cordoba, and P. A. Lazo. 1993. The human CD53 gene, coding for a four transmembrane domain protein, maps to chromosomal region 1p13. Genomics 18:217-221.
11. Guo, X., H. Friess, H. U. Graber, M. Kashigawi, A. Zimmerman, M. Korc, and M. VV. Büchler. 1996. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res. 56: 4876-4880.
12. Hadam, M. R. 1989. Cluster report: CD53, p. 674-678. In W. Knapp, B. Dörken, W. R. Gilks, E. P. Rieber, R. E. Schmidt, H. Stein, and A. E. G. Von dem Borne (ed.), Leukocyte typing, vol. IV. White cell antigen differentiation antigens. Oxford University Press, Oxford, United Kingdom.
13. Higashiyama, M., T. Taki, Y. Ieki, M. Adachi, C. Huang, T. Koh, K. Kodama, O. Doi, and M. Miyake. 1995. Reduced motility related protein 1 (MRP1/ CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res. 55:6040-6044.
14. Horejsi, V., and C. Vlcek. 1991. Novel structurally distinct family of leukocyte surface glycoproteins including CD9, CD37, CD53 and CD63. FEBS Lett. 288:1-4.
15. Ikeyama, S., M. Koyama, M. Yamaoko, R. Sasada, and M. Miyake. 1993. Suppression of cell motility and metastasis by transfection with human motility-rclatcd protein (MRP1/CD9) DNA. J. Exp. Med. 177:1231-1237.
16. Lacal, P., R. Pulido, F. Sanchez-Madrid, and F. Mollinedo. 1988. Intracellular localization of T200 and Mol glycoproteins in human neutrophils. J. Biol. Chem. 263:9946-9951.
17. Mitnacht, R., M. Tacke, and T. Hünig. 1992. Expression of cell interaction molecules by immature rat thymocytes during passage through the CD4+8+ compartment: developmental regulation and induction by T cell receptor engagement of CD2, CD5, CD28, CD11a, CD44 and CD53. Eur. J. Immunol. 25:328-332.
18. Miyake, M., K. Nakano, Y. Ieki, C.-L. Huang, S. Itoi, T. Koh, and T. Taki. 1995. Motility related protein 1 (MRP1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res. 55:4127-4131.
19. Mollinedo, F., B. Martín-Martín, C. Gajate, and P. A. Lazo. Submitted for publication.
20. Mollinedo, F., J. M. Nieto, and J. M. Andreu. 1989. Cytoplasmic microtubules in human neutrophil degranulation: reversible inhibition by the colchicine analog 2-methoxy-5-(2′,3′,4′-trimethoxyphenyl)-2,4,6-cyclohepta- trien-1-one. Mol. Pharmacol. 36:547-555.
21. Olweus, J., F. Lund-Johansen, and V. Horejsi. 1993. CD53, a protein with four membrane-spanning domains, mediates signal transduction in human monocytes and B cells. J. Immunol. 151:707-716.
22. Rasmussen, A. M., H. K. Blomhoff, T. Stokke, V. Horejsi, and E. B. Smeland. 1994. Cross-linking of CD53 promotes activation of resting human B lymphocytes. J. Immunol. 153:4997-5007.
23. Wright, M. D., and M. G. Tomlinson. 1994. The ins and outs of the transmembrane four superfamily. Immunol. Today 15:588-594.